Navigation Links
A novel treatment may reduce myocardial infarction size
Date:2/27/2014

Researchers at the University of Eastern Finland (UEF) have developed a novel treatment for myocardial infarction. In a study carried out at the UEF, virus vectors were used in a mouse model to deliver small RNA molecules into the heart, and this significantly reduced the size of myocardial infarction. In the novel treatment method, RNA molecules are targeted at the regulatory area of the vascular endothelial growth factor gene (VEGF-A). These molecules use epigenetic mechanisms to enhance the production of the growth factor in cells.

The study also focused on the mechanisms of this new treatment, epigenetherapy, in cell models. The study was carried out in collaboration between researchers of the MRI Research Group at the A.I. Virtanen Institute for Molecular Sciences at the UEF, the University of Jyvskyl, and Temple University in Philadelphia. The study was published in PLOS ONE on 26 February.


'/>"/>
Contact: Seppo Ylä-Herttuala
seppo.ylaherttuala@uef.fi
358-403-552-075
University of Eastern Finland
Source:Eurekalert

Page: 1

Related medicine news :

1. A new target for cancer and diabetes: A novel role for the adaptor protein p66shc in regulating glucose metabolism
2. Novel compound keeps Parkinsons symptoms at bay in mice
3. New company to develop novel gene therapies
4. Novel technique increases detection rate in screening mammography
5. Researchers find novel approach for controlling deadly C. difficile infections
6. Novel genes determine division of labor in insect societies
7. Novel biomarker approach suggests new avenues to improve schizophrenia disease management
8. Development of a novel dual JAK/Src kinase inhibitor
9. Jesus Was Not Born On December 25th - Controversial New Novel Tells Compelling Story About His Birth, Life and Death
10. Fatigue, a common side effect of breast cancer treatment, evaluated in novel patient study
11. Novel drug regimen can improve stem cell transplantation outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... San Francisco, CA (PRWEB) , ... May 26, 2016 , ... ... 1st, 2016, from 6pm to 7.30pm PST at HP in Palo Alto, CA. This ... panel discussion will be led by clinical trial experts from the pharmaceutical company Hallux, ...
(Date:5/25/2016)... ... May 25, 2016 , ... “We are ... Partner at HealthScape Advisors. “Brad brings significant experience advising healthcare provider clients throughout ... accelerates with the implementation of MACRA, we believe that continuing to add professionals ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... The Georgia ... Award of Excellence from the Atlanta Urban Design Commission. , The annual award recognizes ... city of Atlanta’s built environment, the preservation of its physical heritage and the balance ...
(Date:5/25/2016)... ... 2016 , ... Serenity Recovery, a holistic treatment center for ... the many supplemental program options offered at their rehabilitation facility, this time focusing ... Belt in the Shorin-ryu style of Karate that originated in Okinawa, Japan, and ...
(Date:5/25/2016)... ... ... to an article published May 5th on The Daily Mail, a survey pointed ... it found that more than a third cited unappealing breath a one of their top ... a failure to brush after meals, can typically be attributed to gum disease. Moreover, the ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
(Date:5/25/2016)... India , May 25, 2016 ... Animation Market by Type (3D, 2D, 4D), by Therapeutic ... Education), by End User (Medical Device Manufacturers, Hospitals/ Clinics) ... studies the global Medical Animation Market for the forecast ... to reach USD 301.3 Million by 2021 from USD ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... dringenden Bedarf zur Steuerung ... N.V. (NASDAQ: QGEN ; Frankfurt Prime ... Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung und ... sein. Ein erstes Projekt wird die Entwicklung und ...
Breaking Medicine Technology: